[1] S. Tran, P. DeGiovanni, B. Piel, P. Rai, Cancer nanomedicine: a review of recent
success in drug delivery, Clin. Transl. Med. 6 (2017), https://doi.org/10.1186/
s40169-017-0175-0.
[2] S. Her, D.A. Jaffray, C. Allen, Gold nanoparticles for applications in cancer
radiotherapy: mechanisms and recent advancements, Adv. Drug Deliv. Rev. 109
(2017) 84–101, https://doi.org/10.1016/j.addr.2015.12.012.
[3] M.F. Attia, J. Wallyn, N. Anton, T.F. Vandamme, Inorganic nanoparticles for X-ray
computed tomography imaging, Crit. Rev. Ther. Drug Carrier Syst. 35 (2018)
391–432, https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2018020974.
[4] N. Elahi, M. Kamali, M.H. Baghersad, Recent biomedical applications of gold
nanoparticles: a review, Talanta 184 (2018) 537–556, https://doi.org/10.1016/
j.talanta.2018.02.088.
[5] D.L. Xia, Y.F. Wang, N. Bao, H. He, X. dong Li, Y.P. Chen, H.Y. Gu, Influence of
reducing agents on biosafety and biocompatibility of gold nanoparticles, Appl.
4. Conclusion
EGCG-AuNP 15 nm in diameter in the presence of sodium alginate
accumulated more in tumors after intravenous injection into mice
compared to 40-nm-diameter EGCG-AuNP. The AuNP surface was
modified with EGCG but no 67LR-mediated tumor accumulation was
observed. The results of in vitro cellular uptake and serum protein absorption suggest that 15–16 kDa serum proteins including hemoglobin
C. Wakayama et al.
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
JCIS Open 9 (2023) 100074
[21] W.H. De Jong, W.I. Hagens, P. Krystek, M.C. Burger, A.J.A.M. Sips, R.E. Geertsma,
Particle size-dependent organ distribution of gold nanoparticles after intravenous
administration, Biomaterials 29 (2008) 1912–1919, https://doi.org/10.1016/
j.biomaterials.2007.12.037.
[22] G. Sonavane, K. Tomoda, K. Makino, Biodistribution of colloidal gold nanoparticles
after intravenous administration: effect of particle size, Colloids Surf. B
Biointerfaces 66 (2008) 274–280, https://doi.org/10.1016/j.colsurfb.2008.07.004.
[23] R. Terg, C.D. Miguez, L. Castro, H. Araldi, S. Dominguez, M. Rubio,
Pharmacokinetics of Dextran-70 in patients with cirrhosis and ascites undergoing
therapeutic paracentesis, J. Hepatol. 25 (1996) 329–333, https://doi.org/10.1016/
S0168-8278(96)80119-X.
[24] S.L. Easo, P. V Mohanan, Hepatotoxicity evaluation of dextran stabilized iron oxide
nanoparticles in Wistar rats, Int. J. Pharm. 509 (2016) 28–34, https://doi.org/
10.1016/j.ijpharm.2016.05.026.
[25] X. Zhang, M.R. Servos, J. Liu, Ultrahigh nanoparticle stability against salt, pH, and
solvent with retained surface accessibility via depletion stabilization, J. Am. Chem.
Soc. 134 (2012) 9910–9913, https://doi.org/10.1021/ja303787e.
[26] Y. Zhao, F. Li, M.T. Carvajal, M.T. Harris, Interactions between bovine serum
albumin and alginate: an evaluation of alginate as protein carrier, J. Colloid
Interface Sci. 332 (2009) 345–353, https://doi.org/10.1016/j.jcis.2008.12.048.
[27] L. Ding, C. Yao, X. Yin, C. Li, Y. Huang, M. Wu, B. Wang, X. Guo, Y. Wang, M. Wu,
Size, shape, and protein corona determine cellular uptake and removal mechanisms
of gold nanoparticles, Small 14 (2018) 1–13, https://doi.org/10.1002/
smll.201801451.
[28] G. Maiorano, S. Sabella, B. Sorce, V. Brunetti, M. Ada Malvindi, R. Cingolani,
P. Paolo Pompa, Effects of cell culture media on the dynamic formation of
ProteinNanoparticle complexes and influence on the cellular response, ACS Nano
4 (2010) 7481–7491, https://doi.org/10.1021/nn101557e.
[29] X. Zheng, H. Baker, W.S. Hancock, F. Fawaz, M. McCaman, E. Pungor, Proteomic
analysis for the assessment of different lots of fetal bovine serum as a raw material
for cell culture. Part IV. Application of proteomics to the manufacture of biological
drugs, Biotechnol. Prog. 22 (2006) 1294–1300, https://doi.org/10.1021/
bp060121o.
[30] U. Sakulkhu, M. Mahmoudi, L. Maurizi, G. Coullerez, M. Hofmann-Amtenbrink,
M. Vries, M. Motazacker, F. Rezaee, H. Hofmann, Significance of surface charge and
shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/
shell nanoparticles on the composition of the protein corona, Biomater. Sci. 3
(2015) 265–278, https://doi.org/10.1039/c4bm00264d.
[31] R. Guo, R. Li, X. Li, L. Zhang, X. Jiang, B. Liu, Dual-functional alginic acid hybrid
nanospheres for cell imaging and drug delivery, Small 5 (2009) 709–717, https://
doi.org/10.1002/smll.200801375.
[32] S. Garabagiu, A spectroscopic study on the interaction between gold nanoparticles
and hemoglobin, Mater. Res. Bull. 46 (2011) 2474–2477, https://doi.org/10.1016/
j.materresbull.2011.08.032.
[33] I.F. Tannock, D. Rotin, Acid pH in tumors and its potential for therapeutic
exploitation, Cancer Res. 49 (1989) 4373–4384.
[34] S. Amara, V. Tiriveedhi, Inflammatory role of high salt level in tumor
microenvironment (Review), Int. J. Oncol. 50 (2017) 1477–1481, https://doi.org/
10.3892/ijo.2017.3936.
[35] E. Sahin, A.O. Grillo, M.D. Perkins, C.J. Roberts, Comparative effects of pH and
ionic strength on protein–protein interactions, unfolding, and aggregation for IgG1
antibodies, J. Pharmaceut. Sci. 99 (2010) 4830–4848, https://doi.org/10.1002/
jps.22198.
[36] Y.T. Ho, N. ‘Ain Azman, F.W.Y. Loh, G.K.T. Ong, G. Engudar, S.A. Kriz, J.C.Y. Kah,
Protein corona formed from different blood plasma proteins affects the colloidal
stability of nanoparticles differently, Bioconjugate Chem. 29 (2018) 3923–3934,
https://doi.org/10.1021/acs.bioconjchem.8b00743.
Biochem. Biotechnol. 174 (2014) 2458–2470, https://doi.org/10.1007/s12010014-1193-7.
J. Woong Lee, S.-R. Choi, J. Hyuk Heo, Simultaneous stabilization and
functionalization of gold nanoparticles via biomolecule conjugation: progress and
perspectives, ACS Appl. Mater. Interfaces 13 (2021) 42311–42328, https://doi.org/
10.1021/acsami.1c10436.
N.S. Abadeer, C.J. Murphy, Recent progress in cancer thermal therapy using gold
nanoparticles, J. Phys. Chem. C 120 (2016) 4691–4716, https://doi.org/10.1021/
acs.jpcc.5b11232.
J.A. Dahl, B.L.S. Maddux, J.E. Hutchison, Toward Greener Nanosynthesis, 2007,
pp. 2228–2269, https://doi.org/10.1021/cr050943k.
cík, Methods of gold and
P. Slepicka, N.S. Kas
alkova, J. Siegel, Z. Kolska, V. Svor
silver nanoparticles preparation, Materials 13 (2020) 1, https://doi.org/10.3390/
ma13010001.
I. Ojea-Jimenez, F.M. Romero, N.G. Bastús, V. Puntes, Small gold nanoparticles
synthesized with sodium citrate and heavy water: insights into the reaction
mechanism, J. Phys. Chem. C 114 (2010) 1800–1804, https://doi.org/10.1021/
jp9091305.
B.K. Pong, H.I. Elim, J.X. Chong, W. Ji, B.L. Trout, J.Y. Lee, New insights on the
nanoparticle growth mechanism in the citrate reduction of gold(III) salt: formation
of the Au nanowire intermediate and its nonlinear optical properties, J. Phys. Chem.
C 111 (2007) 6281–6287, https://doi.org/10.1021/jp068666o.
V. Sanna, N. Pala, G. DessI, P. Manconi, A. Mariani, S. Dedola, M. Rassu, C. Crosio,
C. Iaccarino, M. Sechi, Single-step green synthesis and characterization of goldconjugated polyphenol nanoparticles with antioxidant and biological activities, Int.
J. Nanomed. 9 (2014) 4935–4951, https://doi.org/10.2147/IJN.S70648.
S. Zhu, L. Zhu, J. Yu, Y. Wang, B. Peng, Anti-osteoclastogenic effect of
epigallocatechin gallate-functionalized gold nanoparticles in vitro and in vivo, Int.
J. Nanomed. 14 (2019) 5017–5032, https://doi.org/10.2147/IJN.S204628.
N. Gan, C. Wakayama, S. Inubushi, T. Kunihisa, S. Mizumoto, M. Baba, H. Tanino,
T. Ooya, Size dependency of selective cellular uptake of epigallocatechin gallatemodified gold nanoparticles for effective radiosensitization, ACS Appl. Bio Mater. 5
(2022) 355–365, https://doi.org/10.1021/acsabm.1c01149.
C.C. Chen, D.S. Hsieh, K.J. Huang, Y.L. Chan, P. Da Hong, M.K. Yeh, C.J. Wu,
Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in
murine B16F10 melanoma cells, Drug Des. Dev. Ther. 8 (2014) 459–473, https://
doi.org/10.2147/DDDT.S58414.
S.R. Chavva, S.K. Deshmukh, R. Kanchanapally, N. Tyagi, J.W. Coym, A.P. Singh,
S. Singh, Epigallocatechin gallate-gold nanoparticles exhibit superior antitumor
activity compared to conventional gold nanoparticles: potential synergistic
interactions, Nanomaterials 9 (2019), https://doi.org/10.3390/nano9030396.
D.S. Hsieh, H. Wang, S.W. Tan, Y.H. Huang, C.Y. Tsai, M.K. Yeh, C.J. Wu, The
treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold
nanoparticles, Biomaterials 32 (2011) 7633–7640, https://doi.org/10.1016/
j.biomaterials.2011.06.073.
O. Oladimeji, J. Akinyelu, A. Daniels, M. Singh, Modified gold nanoparticles for
efficient delivery of betulinic acid to cancer cell mitochondria, Int. J. Mol. Sci. 22
(2021), https://doi.org/10.3390/ijms22105072.
M.Y. Chang, A.L. Shiau, Y.H. Chen, C.J. Chang, H.H.W. Chen, C.L. Wu, Increased
apoptotic potential and dose-enhancing effect of gold nanoparticles in combination
with single-dose clinical electron beams on tumor-bearing mice, Cancer Sci. 99
(2008) 1479–1484, https://doi.org/10.1111/j.1349-7006.2008.00827.x.
R. Shukla, N. Chanda, A. Zambre, A. Upendran, K. Katti, R.R. Kulkarni, S.K. Nune,
S.W. Casteel, C.J. Smith, J. Vimal, E. Boote, J.D. Robertson, P. Kan, H. Engelbrecht,
L.D. Watkinson, T.L. Carmack, J.R. Lever, C.S. Cutler, C. Caldwell, R. Kannan,
K.V. Katti, Laminin receptor specific therapeutic gold nanoparticles (198AuNPEGCg) show efficacy in treating prostate cancer, Proc. Natl. Acad. Sci. U.S.A. 109
(2012) 12426–12431, https://doi.org/10.1073/pnas.1121174109.
...
論文の公開元へ
